Volitionrx (VNRX) Equity Ratio (2011 - 2025)
Volitionrx posted quarterly Equity Ratio of 5.16 for Q4 2025, down 94.63% year-on-year from 96.04 in Q4 2024, and up 7.48% on a QoQ basis from 5.57 in Q3 2025.
Volitionrx (VNRX) has 11 years of Equity Ratio data on file, last reported at 5.16 in Q4 2025.
- For the quarter ending Q4 2025, Equity Ratio fell 94.63% year-over-year to 5.16; the trailing twelve-month figure through Dec 2025 stood at 5.16 (down 94.63% YoY), and the FY2025 full-year result was 5.16, down 94.63% from the prior year.
- Equity Ratio for Q4 2025 stood at 5.16, up from 5.57 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.76 in Q2 2021 and bottomed at 5.57 in Q3 2025.
- The 5-year median for Equity Ratio is 0.17 (2022), against an average of 1.2.
- The widest annual swing landed in 2023, when Equity Ratio increased 10.84%; it then slumped 1043.54% in 2024.
- A 5-year view of Equity Ratio shows it stood at 0.64 in 2021, then slumped by 126.51% to 0.17 in 2022, then sank by 82.37% to 0.31 in 2023, then tumbled by 750.13% to 2.65 in 2024, then tumbled by 94.63% to 5.16 in 2025.
- The last three Equity Ratio figures came in at 5.16 (Q4 2025), 5.57 (Q3 2025), and 3.8 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.47 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.50 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.54 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.59 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.78 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.45 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.29 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.67 |
| 10 | Volitionrx | 101.83 Mn | 99.36 Mn | -1.01 Mn | -5.16 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.16 |
| Sep 30, 2025 | -5.57 |
| Jun 30, 2025 | -3.80 |
| Mar 31, 2025 | -3.41 |
| Dec 31, 2024 | -2.65 |
| Sep 30, 2024 | -1.79 |
| Jun 30, 2024 | -1.75 |
| Mar 31, 2024 | -0.86 |
| Dec 31, 2023 | -0.31 |
| Sep 30, 2023 | -0.16 |
| Jun 30, 2023 | 0.19 |
| Mar 31, 2023 | -0.17 |
| Dec 31, 2022 | -0.17 |
| Sep 30, 2022 | 0.12 |
| Jun 30, 2022 | 0.17 |
| Mar 31, 2022 | 0.34 |
| Dec 31, 2021 | 0.64 |
| Sep 30, 2021 | 0.71 |
| Jun 30, 2021 | 0.76 |
| Dec 31, 2020 | 0.62 |
| Mar 31, 2020 | 0.54 |
| Dec 31, 2019 | 0.67 |
| Sep 30, 2019 | 0.75 |
| Jun 30, 2019 | 0.72 |
| Dec 31, 2018 | 0.69 |
| Jun 30, 2013 | 0.27 |
| Mar 31, 2013 | 0.31 |
| Dec 31, 2012 | 0.38 |
| Sep 30, 2012 | 0.51 |
| Jun 30, 2012 | 0.54 |
| Mar 31, 2012 | 0.44 |
| Dec 31, 2011 | 0.49 |